November 29, 2021
Life Sciences
  • BioNTech SE and Moderna Inc. are adjusting their COVID-19 vaccines to fight the omicron variant. BioNTech said it could have a new version of its shot ready within 100 days. The drugmakers are starting development as research continues on whether new shots are needed at all. (Articles here and here)